YOUR HEALTH. A MORE INFORMED VIEW.
A defined ANA-related antibody profile to support a clinician-led autoimmune assessment.
CLINICAL AUTHORDr Nirupama SabhapathySpecialist Clinical Pathology
THE PURPOSE BEHIND THE PANEL.
The panel examines the listed antibody targets rather than measuring general immunity. Antibody patterns may contribute to a specialist assessment when symptoms and examination suggest an autoimmune condition. A positive antibody is not equivalent to a diagnosis, and results should not be interpreted independently of the person.
5named targets5 listed entries
This view contains 5 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
The profile does not diagnose an autoimmune disease on its own and a negative result does not exclude every autoimmune condition.
4named targets4 listed entries
This view contains 4 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
The profile does not diagnose an autoimmune disease on its own and a negative result does not exclude every autoimmune condition.
8named targets8 listed entries
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
The profile does not diagnose an autoimmune disease on its own and a negative result does not exclude every autoimmune condition.
KNOW EXACTLY WHAT YOU ARE CHOOSING.
The headline count follows the source’s named-entry convention. Some entries may be grouped targets, mixtures or assay components; the exact source list below defines the scope.
17 named target entries · 17 Antibodies
This view contains 5 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 5 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 5 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 5 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 5 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 4 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 4 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 4 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 4 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Try a test or target name, or choose another health focus.
Checking a prescription?
Let’s make sure it matches.
THE RIGHT START DEPENDS ON YOU.
Choose the investigation around the question you want to discuss. The profile does not diagnose an autoimmune disease on its own and a negative result does not exclude every autoimmune condition.
The panel examines the listed antibody targets rather than measuring general immunity. Antibody patterns may contribute to a specialist assessment when symptoms and examination suggest an autoimmune condition. A positive antibody is not equivalent to a diagnosis, and results should not be interpreted independently of the person.
Compare the full included list with your clinician’s request. The profile does not diagnose an autoimmune disease on its own and a negative result does not exclude every autoimmune condition.
Bring earlier results and the relevant symptom or treatment history. The clinician can decide whether this scope, a smaller test selection or a different investigation is the most useful next step.
MAKE THE SAMPLE COUNT.
Preparation follows the actual specimen and tests in Auto Immunity – ANA Profile. Confirm your personal instructions before collection.
A personal checklist. Your care team confirms the instructions.
YOUR COLLECTION. YOUR CHOICE.
Both routes lead to the same defined package. Choose the location during checkout; this package waives the collection fee for its visit.
YOUR PLACE. THE SAME LABORATORY PATHWAY.
Discuss collection at your home, hotel or workplace in Dubai. The care team confirms the appropriate specimen, preparation and collection arrangements for this package.
Across DubaiTHE LABORATORY. READY TO WELCOME YOU.
Intel Lab · Deira
101–102, Al Hawai Building, Al Rigga Road, Al Muraqqabat, Deira, Dubai
DEIRA · DUBAI101–102Al Hawai Building
Al Rigga Road
FROM BOOKING TO UNDERSTANDING.
Follow Auto Immunity – ANA Profile from your care bag to an informed conversation.
The right package. The right person.
Add Auto Immunity – ANA Profile to your care bag. Book for yourself or assign the package to someone else. The care team can help match the selection to a request or prescription.
Preparation follows the test.
Confirm the instructions for blood and the appropriate collection arrangements. Correct identification, specimen choice and timing support a useful result.
Laboratory work, behind the finding.
Intel Lab processes the sample and checks the report. The package lists 7 to 8 days; collection timing and any additional laboratory checks may affect release.
A finding, placed in your context.
Read the report with the reason for testing. A clinician can explain unexpected findings, relevant limitations and whether any further assessment is appropriate.
MORE THAN A LIST OF NUMBERS.
Your report brings the measurements together. Explore the findings below to see which questions make the report more meaningful.
UNDERSTANDING YOUR REPORTBlood
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
RESULT + CONTEXT
This view contains 5 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. The profile does not diagnose an autoimmune disease on its own and a negative result does not exclude every autoimmune condition.
UNDERSTANDING YOUR REPORTBlood
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
RESULT + CONTEXT
This view contains 4 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. The profile does not diagnose an autoimmune disease on its own and a negative result does not exclude every autoimmune condition.
UNDERSTANDING YOUR REPORTBlood
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
RESULT + CONTEXT
This view contains 8 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. The profile does not diagnose an autoimmune disease on its own and a negative result does not exclude every autoimmune condition.
THE NEXT STEP IS PERSONAL.
Connect the laboratory findings with the reason for this specific test. A report supports the next clinical conversation; it does not decide it for you.
Review relevant antibody findings with the symptom history, examination and other investigations. The pattern can guide further assessment, but should not become a diagnosis without clinical context.
Discuss this result with a clinician who knows the reason for testing. Further investigations or follow-up depend on the actual findings and your circumstances.
THE LABORATORY BEHIND YOUR RESULTS.
Intelligent Care brings the collection to you. Intel Lab brings the laboratory pathway, from sample handling to reporting.
Accurate patient details, the correct specimen and clear collection instructions are the first part of a reliable laboratory pathway. Follow the collection team’s instructions for the specimens required by this panel.
The laboratory’s analytical work and quality processes support the measurements in the report. Explore the laboratory’s published quality standards and accreditation scope for the detail behind its services.
Reporting connects the laboratory findings with their clinical use. Unexpected or significant results may need additional checks or communication with the referring clinician.
EXPERTISE WITH A NAME.
Laboratory content belongs with laboratory expertise. Explore the clinical profiles and their Dubai Health Authority directory records.
Clinical author
Laboratory Director · Intel Lab
Dr Nirupama Sabhapathy is a DHA-licensed Specialist in Clinical Pathology at Intel Lab. Her published Intel Lab profile describes more than 25 years in medicine and her role as Laboratory Director.
Clinical reviewer
Specialist Clinical Pathology · Intel Lab
Dr Joyce Jose is a DHA-licensed Specialist in Clinical Pathology at Intel Lab. Her public professional record includes pathology practice in the UAE and earlier experience as a professor at Gulf Medical University.
CHOOSE BY PURPOSE, NOT JUST COUNT.
Related packages may ask different questions. Compare their actual scope and discuss which, if any, is appropriate for you.
You are viewingAntinuclear antibody (ANA) screening to help detect autoimmune conditions such as lupus and other connective-tissue disorders.
TSH, FT4 and FT3 from one blood sample, to check for an underactive or overactive thyroid.
Blood count, liver, kidney, cholesterol, blood sugar and urine tests: the essentials in one visit.
Creatinine, eGFR, urea nitrogen, uric acid and calcium from one blood sample, to check how well your kidneys are functioning.
Choosing for a particular need?
We can help you read the options.
BEFORE YOU BOOK.
Preparation, sample types, timing and what the package does—and does not—include.
A defined ANA-related antibody profile to support a clinician-led autoimmune assessment. The full named inventory on this page is the scope of the package.
No. Some antibodies can be found without a diagnosed autoimmune disease. The target, strength, other findings and clinical history guide interpretation.
No. It is a defined set of autoantibody measurements, not a general immune-strength score.
No. Autoimmune conditions and the usefulness of particular antibodies vary. Symptoms and other investigations remain relevant.
No. The combined pattern and the clinical assessment determine what follow-up may be appropriate.
This package does not require fasting for this testing. Confirm whether any additional tests in your booking change that instruction; do not alter prescribed medicines without advice.
Yes. Choose home collection across Dubai or a visit to Intel Lab in Deira. Any health package waives the collection fee for its own visit; separate appointments are assessed separately.
The package price is AED 459; the listed turnaround is 7 to 8 days. Confirm collection and processing arrangements with the team. Turnaround is not a guarantee that every result will be released at one exact time.
Review relevant findings with a qualified clinician alongside the reason for testing, symptoms, medicines and prior results. The report may lead to reassurance about the tested question, confirmation, a targeted investigation or follow-up—not an automatic treatment decision.
YOUR NEXT STEP. AROUND YOU.
Auto Immunity – ANA Profile · 17 Antibodies · Blood